Dr Catherine Alix-Panabieres, PhD - University Medical Center Montpellier - Maître de Conférences des Universités - Praticien Hospitalier

Dr Catherine Alix-Panabieres

PhD

University Medical Center Montpellier

Maître de Conférences des Universités - Praticien Hospitalier

MONTPELLIER | FRANCE

Main Specialties: Other

Additional Specialties: Circulating Tumor Cells

Dr Catherine Alix-Panabieres, PhD - University Medical Center Montpellier - Maître de Conférences des Universités - Praticien Hospitalier

Dr Catherine Alix-Panabieres

PhD

Introduction

Dr Catherine Alix-Panabières received her PhD degree in 1998 at the Institute of Virology, University Louis Pasteur, in Strasbourg in France. In 1999, she moved to Montpellier where she did a postdoctoral research in the Department of Immuno-Virology of the University Medical Centre of Montpellier, France. During this last decade, Dr Alix-Panabières has focused on optimizing new techniques of enrichment and detection of viable disseminating tumor cells in patients with solid tumors. She is the expert for the EPISPOT technology that is used to detect viable tumor cells in the peripheral blood and the bone marrow of patients with breast, prostate, colon, head & neck cancer and melanoma.

In 2010, she achieved getting a permanent position at the Hospital and at the Faculty of Medicine of Montpellier (MCU-PH), a wonderful mixture of giving teaching lessons to medical students on Cancer Biology in combination of developing this field of tumor cell dissemination at the hospital for the cancer patients, leading strongly translational clinical research. As an associate professor, she recently became the new director of the Laboratory of Rare Human Circulating Cells (LCCRH) in the Department of Cell & Tissue Biopathology of tumors.
In this unique platform LCCRH, they isolate, detect and characterize circulating tumor cells using combinations of the EPISPOT assay, the CellSearch® system (Janssen), the flow cytometry, the CellCollector (GILUPI), the molecular biology (AmpliSpeed device), the Parsortix system and the DEPArray (Silicon Biosystem) for single cell sorting. She has authored or co-authored >45 scientific publications in this field during the last years plus 10 book chapters and she is part of two big European projects: CTC-SCAN (Transcan project) and CANCER-ID (IMI project).

After she got the Scientific Prize given by the Region Languedoc-Roussillon in 2008, it was a great honor for her to receive the Gallet et Breton Cancer Prize, the highest honor conferred by the French Academy of Medicine in November 2012.

Primary Affiliation: University Medical Center Montpellier - MONTPELLIER , FRANCE

Specialties:

Additional Specialties:

Publications

54Publications

1585Reads

-Profile Views

2060PubMed Central Citations

Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.

Clin Chem 2017 03 22;63(3):700-713. Epub 2016 Dec 22.

University of Montpellier, UFR de Médecine, Montpellier, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2016.263582DOI Listing
March 2017
26 Reads
7 Citations
7.911 Impact Factor

Epithelial-mesenchymal plasticity in circulating tumor cells.

J Mol Med (Berl) 2017 02 24;95(2):133-142. Epub 2016 Dec 24.

Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://www.goedoc.uni-goettingen.de/goescholar/bitstream/han
Web Search
http://dx.doi.org/10.1007/s00109-016-1500-6DOI Listing
February 2017
39 Reads
5 Citations
5.110 Impact Factor

Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?

Clin Chem 2016 08 3;62(8):1054-60. Epub 2016 Jun 3.

Associate Professor, University Medical Center of Montpellier, Hôpital Saint-Eloi - CHRU Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2016.260331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326709PMC
August 2016
27 Reads
8 Citations
7.911 Impact Factor

Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.

Expert Rev Mol Diagn 2015 21;15(11):1411-7. Epub 2015 Sep 21.

c 3 Department of Tumor Biology, University Medical Centre Hamburg-Eppendorf , Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2015.1091729DOI Listing
August 2016
28 Reads
5 Citations
3.520 Impact Factor

Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.

Am J Transplant 2016 08 8;16(8):2384-94. Epub 2016 Apr 8.

Department of Nephrology, Transplantation and Dialysis, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajt.13781DOI Listing
August 2016
13 Reads
3 Citations
5.683 Impact Factor

Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism.

Clin Transplant 2016 07 23;30(7):810-8. Epub 2016 May 23.

Unidad de Trasplante Hepático, Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.12754DOI Listing
July 2016
19 Reads
1.490 Impact Factor

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.

Cancer Discov 2016 05 11;6(5):479-91. Epub 2016 Mar 11.

Department of Tumor Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/content/6/5/479.full
Web Search
http://dx.doi.org/10.1158/2159-8290.CD-15-1483DOI Listing
May 2016
42 Reads
111 Citations
15.930 Impact Factor

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Apr;374(17):1621-34

From University Hospital Hôtel Dieu, Nantes (P.M., C.T.), the Department of Hematology, Institut Paoli-Calmettes, Marseille (A.-M.S.), and the Department of Hematology and Cell Therapy, Hospital Saint Antoine, Paris (L.G.) - all in France; the Department of Haematology and Stem Cell Transplantation, St. István and St. László Hospital, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary (T.M.); the Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, and St. John's Cancer Center, Lublin, Poland (N.G.); Southern Alberta Cancer Research Institute, University of Calgary, Calgary (N.J.B.), and the Division of Hematology, Department of Medicine, University of Alberta, Edmonton (I.S.) - both in Canada; the Department of Hematology, Skåne University Hospital, Lund University, Lund, Sweden (M.H.); Hematology and Oncology, University Hospital Brno, Brno, Czech Republic (L.P.); the Department of Haematology, Christchurch Hospital, Christchurch (P. Ganly), the Department of Haematology, Palmerston North Hospital, Palmerston North, Manawatu (B.W.B.), the Department of Haematology, Middlemore Hospital, Auckland (S.R.J.), and the Department of Haematology, North Shore Hospital, Auckland (D.R.S.) - all in New Zealand; the Department of Hematology, University Hospital Rigshospitalet, Copenhagen (P. Gimsing); Myeloma Unit, Division of Hematology, University of Turin, Turin (A.P.), and Seràgnoli Institute of Haematology, Bologna University School of Medicine, St. Orsola-Malpighi University Hospital, Bologna (M.C.) - both in Italy; the Division of Hematology, Mayo Clinic, Rochester, MN (S.K., F.K.B.); and Dana-Farber Cancer Institute, Boston (J.P.L., P.G.R.), and Millennium Pharmaceuticals, Cambridge (D.T.B., J.L., A.D.B., A.-M.H., H.V.) - both in Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1516282DOI Listing
April 2016
67 Reads
96 Citations
55.873 Impact Factor

Functional studies on circulating and disseminated tumor cells in carcinoma patients.

Mol Oncol 2016 Mar 18;10(3):443-9. Epub 2016 Jan 18.

Department of Tumor Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528980PMC
March 2016
17 Reads
13 Citations
5.331 Impact Factor

Liquid biopsy: Potential and challenges.

Mol Oncol 2016 Mar 1;10(3):371-3. Epub 2016 Feb 1.

Laboratory of Rare Human Circulating Cells (LCCRH), Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France; EA2415 - Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research (IURC), Montpellier University, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.01.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528972PMC
March 2016
6 Reads
11 Citations
5.331 Impact Factor

Functional Studies on Viable Circulating Tumor Cells.

Clin Chem 2016 Feb 4;62(2):328-34. Epub 2015 Dec 4.

Laboratory of Rare Human Circulating Cells, Department of Cellular and Tissue Biopathology of Tumors, University Medical Centre, Montpellier, France; EA2415-Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research, Montpellier University, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2015.242537DOI Listing
February 2016
17 Reads
12 Citations
7.911 Impact Factor

Cell lines from circulating tumor cells.

Oncoscience 2015 20;2(10):815-6. Epub 2015 Aug 20.

Laboratory of Rare Human Circulating Cells (LCCRH), Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671934PMC
http://dx.doi.org/10.18632/oncoscience.195DOI Listing
December 2015
4 Reads
5 Citations

Frequent expression of PD-L1 on circulating breast cancer cells.

Mol Oncol 2015 Nov 9;9(9):1773-82. Epub 2015 Jun 9.

Laboratory of Rare Human Circulating Cells, Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France; EA2415 - Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research (IURC), Montpellier University, Montpellier, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528721PMC
November 2015
137 Reads
46 Citations
5.331 Impact Factor

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.

EBioMedicine 2015 Oct 13;2(10):1364-76. Epub 2015 Aug 13.

INSERM U1183, Université de Montpellier, UFR Médecine, Montpellier, France ; Institut for Regenerative Medicine and Biotherapy (IRMB), CHU Montpellier, Montpellier 34295, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2015.08.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634619PMC
October 2015
27 Reads
6 Citations

Establishment and characterization of a cell line from human circulating colon cancer cells.

Cancer Res 2015 Mar 15;75(5):892-901. Epub 2015 Jan 15.

Laboratory of Rare Human Circulating Cells (LCCRH), Department of Cellular and Tissular Biopathology of Tumors, University Medical Centre, Montpellier, France. EA2415 - Help for Personalized Decision: Methodological Aspects, University Institute of Clinical Research, Montpellier University, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2613DOI Listing
March 2015
17 Reads
54 Citations
9.330 Impact Factor

Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patients.

Bonekey Rep 2014 19;3:584. Epub 2014 Nov 19.

Laboratory of Rare Human Circulating Cells, Department of Cellular and Tissular Biopathology, Cell and Tissue Biopathology of Tumors Department, Institute of Research in Biotherapy, University Medical Centre, Saint-Eloi Hospital , Montpellier, France ; University Institute of Clinical Research, University Montpellier 1-Epidemiology, Biostatistics and Public Health , Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bonekey.2014.79DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238319PMC
November 2014
9 Reads
20 Citations

Challenges in circulating tumour cell research.

Nat Rev Cancer 2014 09 31;14(9):623-31. Epub 2014 Jul 31.

Department of Tumor Biology, University Medical Center, Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3820DOI Listing
September 2014
140 Reads
209 Citations
37.400 Impact Factor

[The circulating tumor cells: liquid biopsy of cancer].

Klin Lab Diagn 2014 Apr(4):60-4

View Article

Download full-text PDF

Source
April 2014
13 Reads
7 Citations

[Circulating tumor cells: liquid biopsy].

Bull Cancer 2014 Jan;101(1):17-23

Laboratoire des biomarqueurs circulants, SIRIC et département d'oncologie médicale de l'Institut Curie, 26, rue d'Ulm, 75005 Paris, France, Université Paris-Descartes, 12, rue de l'École-de-Médecine, 75270 Paris Cedex 06, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1883DOI Listing
January 2014
36 Reads
1 Citation
0.640 Impact Factor

Technologies for detection of circulating tumor cells: facts and vision.

Lab Chip 2014 Jan 21;14(1):57-62. Epub 2013 Oct 21.

University Medical Centre, Saint-Eloi Hospital, Department of Cellular and Tissue Biopathology of Tumors, Laboratory of Rare Human Circulating Cells (LCCRH), Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c3lc50644dDOI Listing
January 2014
18 Reads
45 Citations

Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.

Clin Chem 2014 Jan 19;60(1):214-21. Epub 2013 Nov 19.

University Medical Centre, Saint-Eloi Hospital, Institute of Research in Biotherapy, Department of Cellular and Tissular Biopathology of tumors, Laboratory of Rare Human Circulating Cells, Montpellier, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2013.215079DOI Listing
January 2014
14 Reads
18 Citations
7.911 Impact Factor

Real-time liquid biopsy in cancer patients: fact or fiction?

Cancer Res 2013 Nov 21;73(21):6384-8. Epub 2013 Oct 21.

Authors' Affiliations: Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; University Medical Centre, Saint-Eloi Hospital, Institute of Research in Biotherapy, Laboratory of Rare Human Circulating Cells, Cell and Tissue Biopathology of Tumors Department; and University Institute of Clinical Research UM1-EA2415-Epidemiology, Biostatistics & Public Health, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-2030DOI Listing
November 2013
12 Reads
86 Citations
9.330 Impact Factor

Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

Clin Chem 2013 Sep 21;59(9):1384-92. Epub 2013 May 21.

Department of Digestive Surgery, Saint-Eloi Hospital, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2013.202846DOI Listing
September 2013
23 Reads
44 Citations
7.911 Impact Factor

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.

Ann Transl Med 2013 Jul;1(2):18

1 University Medical Centre, Saint-Eloi Hospital, Institute of Research in Biotherapy, Department of Cell and Tissue Biopathology of Tumors, Laboratory of Rare Human Circulating Cells, Montpellier, France ; 2 University Institute of Clinical Research UM1-EA2415-Epidemiology, Biostatistics & Public Health, Montpellier, France ; 3 Department of Tumor Biology, Centre of Experimental Medicine, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2013.06.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200637PMC
July 2013
7 Reads
8 Citations

Circulating tumor cells: liquid biopsy of cancer.

Clin Chem 2013 Jan 26;59(1):110-8. Epub 2012 Sep 26.

Laboratory of Rare Human Circulating Cells, Institute of Research in Biotherapy, University Medical Centre, Saint-Eloi Hospital, Montpellier, France.

View Article

Download full-text PDF

Source
http://www.clinchem.org/cgi/doi/10.1373/clinchem.2012.194258
Publisher Site
http://dx.doi.org/10.1373/clinchem.2012.194258DOI Listing
January 2013
100 Reads
224 Citations
7.911 Impact Factor

Plasticity of disseminating cancer cells in patients with epithelial malignancies.

Cancer Metastasis Rev 2012 Dec;31(3-4):673-87

Department of Tumour Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Centre Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-012-9370-zDOI Listing
December 2012
3 Reads
68 Citations
7.234 Impact Factor

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer.

Cancer Discov 2012 Nov 23;2(11):974-5. Epub 2012 Oct 23.

Department of Tumour Biology, Centre of Experimental Medicine, University Cancer Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-12-0432DOI Listing
November 2012
4 Reads
9 Citations
15.930 Impact Factor

Circulating tumor-derived biomarkers in lung cancer.

J Thorac Dis 2012 Oct;4(5):448-9

Department of Tumour Biology, Centre of Experimental Medicine, University Cancer Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2012.08.17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461065PMC
October 2012
14 Reads
4 Citations

Detection methods of circulating tumor cells.

J Thorac Dis 2012 Oct;4(5):446-7

Department of Tumour Biology, Centre of Experimental Medicine, University Cancer Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2012.08.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461061PMC
October 2012
5 Reads
9 Citations

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.

Recent Results Cancer Res 2012 ;195:69-76

Laboratory of Rare Human Circulating Cells, Saint-Eloi Hospital, University Medical Centre, Institute of Research in Biotherapy, University Montpellier 1, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-28160-0_6DOI Listing
July 2012
293 Reads
26 Citations

[Circulating tumor cells and advanced prostate cancer].

Bull Cancer 2012 Jul;99 Suppl 1:S4-15

CHU, service d'urologie-andrologie, place du Professeur-Robert-Debré, 30029 Nîmes Cedex 9, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2012.1565DOI Listing
July 2012
4 Reads
0.640 Impact Factor

Clinical relevance and biology of circulating tumor cells.

Breast Cancer Res 2011 1;13(6):228. Epub 2011 Nov 1.

Department of Tumour Biology, University Medical Centre Hamburg-Eppendorf, Martinistr, 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326546PMC
June 2012
4 Reads
37 Citations

Circulating tumor cells and circulating tumor DNA.

Annu Rev Med 2012 2;63:199-215. Epub 2011 Nov 2.

University Medical Center, Saint-Eloi Hospital, Institute of Research in Biotherapy, Laboratory of Rare Human Circulating Cells, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-062310-094219DOI Listing
May 2012
8 Reads
97 Citations
12.930 Impact Factor

Circulating epithelial cells in patients with benign colon diseases.

Clin Chem 2012 May 28;58(5):936-40. Epub 2011 Dec 28.

Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2011.175570DOI Listing
May 2012
31 Reads
61 Citations
7.911 Impact Factor

Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

Crit Rev Oncol Hematol 2012 Mar 15;81(3):241-56. Epub 2011 Jun 15.

Department of Radiation Oncology, Antoine-Lacassagne Cancer Center, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2011.05.004DOI Listing
March 2012
6 Reads
15 Citations
4.030 Impact Factor

Molecular mechanisms of metastasis.

J Surg Oncol 2011 May;103(6):508-17

Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21690DOI Listing
May 2011
23 Reads
14 Citations
3.244 Impact Factor

Circulating tumour cells in cancer patients: challenges and perspectives.

Trends Mol Med 2010 Sep 29;16(9):398-406. Epub 2010 Jul 29.

Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2010.07.001DOI Listing
September 2010
15 Reads
95 Citations
9.453 Impact Factor

Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.

Eur J Cancer 2010 May 27;46(7):1189-97. Epub 2010 Mar 27.

Department of Gynecology, University Breast Center, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.02.038DOI Listing
May 2010
13 Reads
11 Citations
5.420 Impact Factor

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.

Breast Cancer Res 2009 23;11(3):R39. Epub 2009 Jun 23.

Department of Virology, Lapeyronie Hospital, University Medical Center of Montpellier, Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716508PMC
January 2010
15 Reads
35 Citations

Cancer micrometastases.

Nat Rev Clin Oncol 2009 Jun;6(6):339-51

Institute of Tumour Biology, Center of Experimental Medicine, University Medical Center Hamburg Eppendorf, Martinistrasse 52, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.44DOI Listing
June 2009
34 Reads
172 Citations
14.180 Impact Factor

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

Clin Cancer Res 2009 Feb;15(3):1032-8

Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1910DOI Listing
February 2009
7 Reads
50 Citations
8.722 Impact Factor

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance.

Breast Cancer Res 2008 9;10 Suppl 1:S1. Epub 2008 Apr 9.

Department of Gynecology and Obstetrics, University Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605098PMC
January 2009
7 Reads
26 Citations

Circulating tumor cells and bone marrow micrometastasis.

Clin Cancer Res 2008 Aug;14(16):5013-21

University Medical Center, Lapeyronie Hospital, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-5125DOI Listing
August 2008
6 Reads
69 Citations
8.722 Impact Factor

Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

Clin Chem 2008 Apr 15;54(4):688-96. Epub 2008 Feb 15.

Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2007.099333DOI Listing
April 2008
37 Reads
9 Citations
7.911 Impact Factor

Current status in human breast cancer micrometastasis.

Curr Opin Oncol 2007 Nov;19(6):558-63

University Medical Center, Lapeyronie Hospital, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3282f0ad79DOI Listing
November 2007
6 Reads
13 Citations
4.470 Impact Factor

The clinical significance of circulating tumor cells.

Nat Clin Pract Oncol 2007 Feb;4(2):62-3

Institute of Tumor Biology, University Medical Center, Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0737DOI Listing
February 2007
4 Reads
26 Citations

Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients.

Clin Chem 2005 Aug;51(8):1538-41

Laboratoire de Virologie and Service d'Urologie, Hôpital Lapeyronie, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2005.049445DOI Listing
August 2005
19 Reads
16 Citations
7.911 Impact Factor

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

J Immunol Methods 2005 Apr 12;299(1-2):177-88. Epub 2005 Apr 12.

Laboratoire de Virologie, Hôpital Lapeyronie, av. du Doyen G. Giraud, 34295 Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2005.02.007DOI Listing
April 2005
20 Reads
17 Citations
2.005 Impact Factor

Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy.

AIDS 2002 Sep;16(13):1755-60

From the Département de Virologie Clinique, Hôpitaux Lapeyronie et Saint Eloi, 34295 Montpellier Cedex 5, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200209060-00007DOI Listing
September 2002
7 Reads
9 Citations
5.554 Impact Factor

Top co-authors

Catherine Alix-Panabieres
Catherine Alix-Panabieres

University Medical Center Montpellier

45
Klaus Pantel
Klaus Pantel

University Medical Center Hamburg-Eppendorf

39
Thierry Maudelonde
Thierry Maudelonde

Centre Hospitalier Universitaire de Montpellier

8
Sabine Riethdorf
Sabine Riethdorf

University Medical Center Hamburg-Eppendorf

6
Xavier Rebillard
Xavier Rebillard

University of Regensburg

5
Laure Cayrefourcq
Laure Cayrefourcq

Institute of Research in Biotherapy

5
Tanja Fehm
Tanja Fehm

University of Tuebingen

3
Heidi Schwarzenbach
Heidi Schwarzenbach

University Medical Center Hamburg-Eppendorf

3